Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020

治験サプライの世界市場:製品/サービス(物流/流通、製造、包装、ラベリング)、治験フェーズ、治療分野別分析

◆タイトル:Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020
◆商品コード:MAM-PH-3772
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年10月6日
◆ページ数:134
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、治験サプライの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、サービス別分析、治験段階別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. The global clinical trial supplies market is segmented based on products and services, phases, therapeutic areas, and regions. The logistics and distribution services segment is expected to register the highest growth rate in the clinical trial supplies market, by products and services, during the forecast period. The high growth in this segment is attributed to the globalization of clinical trials and increasing outsourcing services.

The major factors contributing to the growth of the clinical trial supplies market include globalization of clinical trial activities, increasing R&D investments and government support, and rising incidences of various diseases. Furthermore, increasing expansion activities by CROs is another major factor driving the growth of this market.
For instance, in October 2014, Almac expanded its U.K. commercial packaging facility with a significant investment to meet the requirement of Japanese clients. The expansion included an extensive suite of modifications for processing humidity-sensitive drug products; the installation of a new Noack 623 blister line; a custom designed desiccant feeder; and an off-line Hapa Blister-Jet printer. Increasing patent expiry and development of generic drugs and high growth potential in emerging markets has opened an array of opportunities for the clinical trial supplies market. However, factors such as longer approval times for clinical trials are hampering the growth of the market to a certain extent.

Apart from comprehensive geographic and product/service analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product/service portfolios of the top players in the clinical trial supplies market. The report analyzes the clinical trial supplies market by products and services, phases, therapeutic areas, and regions
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the clinical trial supplies market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the clinical trial supplies market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various clinical trial supplies market services and products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the clinical trial supplies market

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 30)
4.1 Clinical Trial Supplies Market
4.2 Market Share, Services vs Regions
4.3 Geographic Analysis: Clinical Trial Supplies Market, By Phase
4.4 Geographic Analysis: Market, By Product
4.5 Lifecycle Analysis, By Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Clinical Trial Supplies: Market Segmentation
5.2.1 By Products and Services
5.2.2 By Phase
5.2.3 By Therapeutic Area
5.2.4 By Region
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Globalization of Clinical Trial Activities
5.3.1.2 Increasing R&D Investments and Government Support
5.3.1.3 Rising Incidences of Various Diseases
5.3.1.4 Increasing Expansion Activities By Cros
5.3.2 Market Restrains
5.3.2.1 Longer Approval Times for Clinical Trials
5.3.3 Opportunities
5.3.3.1 Emerging Markets
5.3.3.2 Increasing Number of Patent Expirations and Development of Generic Drugs
5.4 Industry Trends
5.4.1 Just–In-Time Packaging and Labeling Methods for Clinical Trial Supplies

6 Clinical Trial Supplies Market, By Product and Service (Page No. – 43)
6.1 Introduction
6.2 Manufacturing
6.3 Packaging and Labeling
6.4 Logistics and Distribution

7 Clinical Trial Supplies Market, By Phase (Page No. – 55)
7.1 Introduction
7.2 Phase I
7.3 Phase II
7.4 Phase III and Bioequivalence Studies

8 Clinical Trial Supplies Market, By Therapeutic Area (Page No. – 62)
8.1 Introduction
8.2 Oncology
8.3 Cns and Mental Disorders
8.4 Cardiovascular Diseases
8.5 Infectious Diseases
8.6 Respiratory Diseases
8.7 Blood Disorders
8.8 Dermatology
8.9 Others

9 Clinical Trial Supplies Market, By Region (Page No. – 74)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe (Roe)
9.4 Asia-Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 101)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situations and Trends
10.3.1 Expansion
10.3.2 Agreements, Partnerships, Collaborations, and Joint Venture
10.3.3 Acquisitions
10.3.4 New Product and Service Launches
10.3.5 Others

11 Company Profiles (Page No. – 108)
(Overview, Financials, Products & Services, and Developments)*
11.1 Introduction
11.2 ALMAC Group Ltd,
11.3 Catalent Pharma Solutions, Inc.
11.4 Parexel International
11.5 Thermo Fisher Scientific, Inc.
11.6 PCI Services
11.7 Patheon, Inc.
11.8 Sharp Packaging Services
11.9 Biocair
11.10 Movianto
11.11 Klifo A/S.

*Details on Overview, Financials, Product & Services, and Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 128)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports

List of Tables (70 Tables)

Table 1 Increasing Expansion Activities By Cros to Boost the Market Growth for Clinical Trial Supplies
Table 2 Longer Approval Times for Clinical Trials are Restraining the Growth of the Market
Table 3 Growth Prospects in Emerging Countries to Fuel the Market Growth
Table 4 Clinical Trial Supplies Market Size, By Product and Service, 2013–2020 (USD Million)
Table 5 Market Size, By Region, 2013–2020 (USD Million)
Table 6 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 7 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 8 Asia-Pacific: Market Size, By Country, 2013–2020 (USD Million)
Table 9 Clinical Trial Supplies Market Size for Manufacturing Services, By Region, 2013–2020 (USD Million)
Table 10 North America: Market Size for Manufacturing Services, By Country, 2013–2020 (USD Million)
Table 11 Europe: Market Size for Manufacturing Services, By Country, 2013–2020 (USD Million)
Table 12 Asia-Pacific: Market Size for Manufacturing Services, By Country, 2013–2020 (USD Million)
Table 13 Clinical Trial Supplies Market Size for Packaging and Labeling Services, By Region, 2013–2020 (USD Million)
Table 14 North America: Market Size for Packaging and Labeling Services, By Country, 2013–2020 (USD Million)
Table 15 Europe: Market Size for Packaging and Labeling Services, By Country, 2013–2020 (USD Million)
Table 16 Asia-Pacific: Market Size for Packaging and Labeling Services, By Country, 2013–2020 (USD Million)
Table 17 Clinical Trial Supplies Market Size for Logistics and Distribution Services, By Region, 2013–2020 (USD Million)
Table 18 North America: Market Size for Logistics and Distribution Services, By Country, 2013–2020 (USD Million)
Table 19 Europe: Market Size for Logistics and Distribution Services, By Country, 2013–2020 (USD Million)
Table 20 Asia-Pacific: Market Size for Logistics and Distribution Services, By Country, 2013–2020 (USD Million)
Table 21 Clinical Trial Supplies Market Size, By Phase, 2013–2020 (USD Million)
Table 22 Market Size, By Region, 2013–2020 (USD Million)
Table 23 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 24 Clinical Trial Supplies Market Size for Phase I Trials, By Region, 2013–2020 (USD Million)
Table 25 North America: Market Size for Phase I Trials, By Country, 2013–2020 (USD Million)
Table 26 Clinical Trial Supplies Market Size for Phase II Trials, By Region, 2013–2020 (USD Million)
Table 27 North America: Market Size for Phase II Trials, By Country, 2013–2020 (USD Million)
Table 28 Clinical Trial Supplies Market Size for Phase III Trials, By Region, 2013–2020 (USD Million)
Table 29 North America: Market Size for Phase III Trials, By Country, 2013–2020 (USD Million)
Table 30 Clinical Trial Supplies Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 31 Clinical Trial Supplies Market Size, By Region, 2013–2020 (USD Million)
Table 32 Market Size for Oncology, By Region, 2013–2020 (USD Million)
Table 33 Market Size for Cns and Mental Disorders, By Region, 2013–2020 (USD Million)
Table 34 Market Size for Cardiovascular Diseases, By Region, 2013–2020 (USD Million)
Table 35 Market Size for Infectious Diseases, By Region, 2013–2020 (USD Million)
Table 36 Market Size for Respiratory Diseases, By Region, 2013–2020 (USD Million)
Table 37 Market Size for Blood Disorders, By Region, 2013–2020 (USD Million)
Table 38 Market Size for Dermatology, By Region, 2013–2020 (USD Million)
Table 39 Clinical Trial Supplies Market for Other Applications, By Region, 2013–2020 (USD Million)
Table 40 North America: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 41 North America: Market Size, By Phase, 2013–2020 (USD Million)
Table 42 North America: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 43 U.S.: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 44 U.S.: Market Size, By Phase, 2013–2020 (USD Million)
Table 45 Canada: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 46 Canada: Market Size, By Phase, 2013–2020 (USD Million)
Table 47 Europe: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 48 Europe: Market Size, By Phase, 2013–2020 (USD Million)
Table 49 Europe: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 50 U.K.: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 51 Germany: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 52 France: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 53 Spain: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 54 Italy: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 55 Roe: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 56 Asia-Pacific: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 57 Asia-Pacific: Market Size, By Phase, 2013–2020 (USD Million)
Table 58 Asia-Pacific: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 59 China: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 60 India: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 61 Japan: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 62 RoAPAC: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 63 RoW: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 64 RoW: Market Size, By Phase, 2013–2020 (USD Million)
Table 65 RoW: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 66 Expansions, 2012–2015
Table 67 Agreements, Partnerships, Collaborations, and Joint Venture, 2012–2015
Table 68 Acquisitions, 2012–2015
Table 69 New Product and Service Launches, 2012–2015
Table 70 Others, 2012–2015

List of Figures (36 Figures)

Figure 1 Clinical Trial Supplies Market
Figure 2 Research Design
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, & Region
Figure 6 Data Triangulation Methodology
Figure 7 Clinical Trial Products and Services Market Snapshot, 2015 vs 2020
Figure 8 North America to Dominate the Logistics and Distribution Market From 2015 to 2020
Figure 9 Oncology Segment to Command the Largest Market Share and is Expected to Witness the Highest Growth Rate During the Forecast Period
Figure 10 Phase III to Dominate the Clinical Trial Supplies Market From 2015 to 2020
Figure 11 Clinical Trial Supplies Market, By Region, 2015
Figure 12 Asia-Pacific Region to Witness Highest Growth Rate in the Clinical Trial Supplies Market From 2015 to 2020
Figure 13 Clinical Trial Supplies Market to Showcase Lucrative Growth Opportunities in the Forecast Period
Figure 14 Logistics and Distribution Segment to Account for the Largest Market Share in 2015
Figure 15 Phase III Segment to Grow at the Highest Rate During the Forecast Period
Figure 16 Logistics and Distribution Will Continue to Lead the Market in the Forecast Period
Figure 17 Asia-Pacific Market for Clinical Trial Supplies to Grow at the Highest Rate During the Forecast Period
Figure 18 Market: Drivers, Restraints, and Opportunities
Figure 19 Logistics and Distribution Services Segment Expected to Grow at the Highest CAGR in the Forecast Period
Figure 20 North America Expected to Dominate the Market for Manufacturing Services in the Forecast Period
Figure 21 Phase III Segment is Expected to Dominate the Market in the Forecast Period
Figure 22 Oncology Segment Dominates the Market in 2015
Figure 23 North America Dominates the Oncology Market in 2015
Figure 24 Geographic Snapshot: Emerging Markets Hold Significant Growth Opportunities in the Forecast Period
Figure 25 North America: Market Snapshot
Figure 26 Phase III Segment Will Drive the Growth of the Market in the U.S. in the Forecast Period
Figure 27 Germany is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 28 Asia-Pacific: Market Snapshot
Figure 29 Expansion Was the Major Strategy Adopted Between 2012 and 2015
Figure 30 Market Share, By Key Player, 2014
Figure 31 Battle for Market Share: Expansion, the Most Actively Adopted Strategy By Market Players
Figure 32 Product Benchmarking for Major Players
Figure 33 Catalent Pharma Solutions, Inc.: Company Snapshot
Figure 34 Parexel International: Company Snapshot
Figure 35 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 36 Sharp Packaging Services: Company Snapshot

【レポートのキーワード】

治験サプライ、物流サービス、流通、製造、包装、ラベリング、治験フェーズ、治療、医薬品、治験製品

★調査レポート[治験サプライの世界市場:製品/サービス(物流/流通、製造、包装、ラベリング)、治験フェーズ、治療分野別分析] ( Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020 / MAM-PH-3772) 販売に関する免責事項
[治験サプライの世界市場:製品/サービス(物流/流通、製造、包装、ラベリング)、治験フェーズ、治療分野別分析] ( Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020 / MAM-PH-3772) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆